Black Diamond Therapeutics, Inc. (BDTX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$2.04
Day's range
$2.18

Black Diamond Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 02/19/2026 10.61 M $25.78 M   -1.28% 18.72%
NEA MANAGEMENT COMPANY, LLC 02/17/2026 4.45 M $10.81 M   0.00% 7.85%
VANGUARD GROUP INC 01/29/2026 2.19 M $5.32 M   0.00% 3.86%
ACADIAN ASSET MANAGEMENT LLC 02/10/2026 1.63 M $3.96 M   238.83% 2.88%
MARSHALL WACE, LLP 02/13/2026 1.11 M $2.70 M   -14.56% 1.96%
SIREN, L.L.C. 02/13/2026 1.05 M $2.54 M   0.00% 1.85%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 02/13/2026 1.04 M $2.53 M   16.01% 1.84%
JANE STREET GROUP, LLC 02/12/2026 961.78 K $2.34 M   305.35% 1.70%
RENAISSANCE TECHNOLOGIES LLC 02/12/2026 949.74 K $2.31 M   58.45% 1.68%
BLACKROCK, INC. 02/12/2026 888.26 K $2.16 M   -13.60% 1.57%
VESTAL POINT CAPITAL, LP 02/17/2026 870.00 K $2.11 M   -84.32% 1.54%
DIMENSIONAL FUND ADVISORS LP 02/12/2026 857.02 K $2.08 M   88.00% 1.51%
D. E. SHAW & CO., INC. 02/17/2026 655.77 K $1.59 M   356.53% 1.16%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 02/10/2026 654.70 K $1.59 M   397.36% 1.16%
AWM INVESTMENT COMPANY, INC. 02/13/2026 625.00 K $1.52 M   4.17% 1.10%
FMR LLC 02/17/2026 541.15 K $1.32 M   19.31% 0.96%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 505.78 K $1.23 M   1.05% 0.89%
NORTHERN TRUST CORP 02/17/2026 472.70 K $1.15 M   -3.15% 0.83%
CITADEL ADVISORS LLC 02/17/2026 425.46 K $1.03 M   100.00% 0.75%
WINTON GROUP LTD 02/11/2026 421.28 K $1.02 M   100.00% 0.74%
O'SHAUGHNESSY ASSET MANAGEMENT, LLC 02/11/2026 354.45 K $861.32 K   148.85% 0.63%
MACKENZIE FINANCIAL CORP 02/18/2026 352.45 K $875.88 K   100.00% 0.62%
GOLDMAN SACHS GROUP INC 03/25/2026 325.33 K $790.55 K   -27.55% 0.57%
GLOBEFLEX CAPITAL L P 02/11/2026 305.28 K $741.82 K   0.00% 0.54%
MILLENNIUM MANAGEMENT LLC 02/17/2026 296.56 K $720.63 K   -65.12% 0.52%
STIFEL FINANCIAL CORP 02/13/2026 275.00 K $668.24 K   23.74% 0.49%
J. GOLDMAN & CO LP 02/17/2026 270.00 K $656.10 K   100.00% 0.48%
UBS GROUP AG 01/29/2026 257.63 K $626.05 K   -59.00% 0.45%
683 CAPITAL MANAGEMENT, LLC 02/17/2026 247.96 K $602.54 K   100.00% 0.44%
GSA CAPITAL PARTNERS LLP 02/06/2026 245.72 K $597.00 K   100.17% 0.43%
RITHOLTZ WEALTH MANAGEMENT 01/23/2026 227.87 K $553.72 K   124.55% 0.40%
BANK OF NEW YORK MELLON CORP 02/10/2026 214.67 K $521.65 K   70.82% 0.38%
STATE STREET CORP 02/13/2026 213.51 K $518.84 K   0.00% 0.38%
CANADA PENSION PLAN INVESTMENT BOARD 02/17/2026 203.10 K $493.53 K   100.00% 0.36%
POINT72 ASSET MANAGEMENT, L.P. 02/17/2026 196.74 K $478.08 K   100.00% 0.35%
TD ASSET MANAGEMENT INC 02/10/2026 195.93 K $476.11 K   6.82% 0.35%
DIADEMA PARTNERS LP 02/17/2026 190.40 K $462.67 K   100.00% 0.34%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 02/17/2026 173.30 K $421.12 K   76.30% 0.31%
QUBE RESEARCH & TECHNOLOGIES LTD 02/17/2026 169.62 K $412.17 K   116.72% 0.30%
SUSQUEHANNA PORTFOLIO STRATEGIES, LLC 02/17/2026 158.98 K $386.33 K   -24.68% 0.28%
OMERS ADMINISTRATION CORP 02/13/2026 138.90 K $337.53 K   1,162.73% 0.25%
KENNEDY CAPITAL MANAGEMENT LLC 02/13/2026 133.12 K $323.47 K   2.44% 0.24%
INVESCO LTD. 02/19/2026 131.44 K $319.39 K   37.86% 0.23%
MAN GROUP PLC 02/17/2026 130.03 K $315.98 K   66.02% 0.23%
ROUND ROCK ADVISORS, LLC 04/07/2026 124.56 K $302.69 K   100.00% 0.22%
XTX TOPCO LTD 02/17/2026 119.68 K $290.82 K   -44.64% 0.21%
OXFORD ASSET MANAGEMENT LLP 02/17/2026 114.38 K $277.95 K   100.00% 0.20%
AMERICAN CENTURY COMPANIES INC 02/13/2026 108.11 K $262.70 K   16.96% 0.19%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 104.72 K $254.48 K   100.00% 0.18%
VERDAD ADVISERS, LP 02/17/2026 96.29 K $233.98 K   100.00% 0.17%

Black Diamond Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 139 institutional investors and hedge funds held shares of Black Diamond Therapeutics Inc. The most heavily invested institutionals were:

DIMENSIONAL FUND ADVISORS LP: 1.3 M

Connor, Clark & Lunn Investment Management Ltd.: 1.06 M

UBS Group AG: 564,838

WINTON GROUP Ltd: 538,259

STIFEL FINANCIAL CORP: 278,645

TD ASSET MANAGEMENT INC: 195,930

66.82% of Black Diamond Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 43.70 M shares in the last 24 months. This purchase volume represents approximately $95.26 M in transactions.